Advancing the frontier of translational proteomic insights: Focus on large scale mass spectrometry A fireside conversation for biopharma, investors, and academics about maximizing translational insights from proteomic data by capitalizing on the emergence of large-scale technologies including mass spec and genetics data. Abstract: Despite decades of clinical trial investment, fewer than 10% of drugs reach […]
